If a patient is allergic to heparin, are they also allergic to Activase (alteplase)?

No Cross-Allergy Between Heparin and Activase (Alteplase)

If you have an allergy to heparin, you do NOT have an allergy to Activase (alteplase)—these are completely different medications with distinct mechanisms and no cross-reactivity.

Why There Is No Cross-Allergy

Heparin and alteplase are fundamentally different drug classes with separate allergic profiles:

• Heparin is an anticoagulant derived from porcine intestinal mucosa (animal tissue). True hypersensitivity reactions to heparin are uncommon and typically manifest as delayed-type hypersensitivity (inflammatory skin reactions at injection sites) or, very rarely, immediate IgE-mediated reactions 1, 2.

• Activase (alteplase) is a recombinant tissue plasminogen activator—a thrombolytic agent that is biochemically identical to endogenous human tPA. It is NOT derived from animal sources and has a completely different molecular structure and mechanism of action 3.

Key Clinical Points

Heparin Allergy Characteristics

The FDA label for heparin explicitly states that hypersensitivity reactions should prompt caution due to its animal tissue origin 2. The most common manifestations include:

• Delayed-type hypersensitivity (DTH) with inflammatory skin reactions at subcutaneous injection sites (96% of heparin allergies) 4
• Rare immediate-type reactions with urticaria, chills, fever, or anaphylaxis 1
• Heparin-induced thrombocytopenia (HIT), which is an immune-mediated complication but NOT a true allergy 1, 5, 1, 6

Alteplase Allergy Characteristics

Alteplase can cause its own hypersensitivity reactions, but these are independent of heparin allergy 3:

• Urticaria, angioedema, anaphylactoid reactions (rare: 0.18-6.12% depending on the agent) 7, 8, 9
• Often associated with concomitant ACE inhibitor use 3
• One case report describes allergic reaction to intraluminal alteplase with negative skin testing, suggesting non-IgE mediated mechanisms 10

Clinical Algorithm

If a patient has documented heparin allergy:

1. Proceed with alteplase if clinically indicated (e.g., acute ischemic stroke, MI, PE)—there is no contraindication based on heparin allergy alone 3

2. Monitor for alteplase-specific hypersensitivity during and for 2 hours after infusion, as you would for any patient receiving alteplase 3

3. Be aware of concomitant heparin use: Many protocols combine alteplase with heparin for certain indications (e.g., alteplase for acute MI or PE) 11, 12, 13, 12, 13. If the patient has true heparin allergy:

   • Use alternative anticoagulation (e.g., bivalirudin, argatroban) if anticoagulation is needed alongside thrombolysis
   • For delayed-type heparin hypersensitivity (skin reactions), intravenous UFH is often tolerated despite subcutaneous intolerance 4

Important Caveats

• Alpha-gal syndrome: Patients with alpha-gal allergy (red meat allergy from tick bites) may react to porcine-derived heparin products, but this does NOT extend to alteplase 14. Heparin reactions in alpha-gal patients are rare (2.6% for UFH, 0% for enoxaparin) 14.

• Protamine allergy: Patients with fish allergy, prior protamine-containing insulin use, or vasectomy history are at higher risk for protamine reactions (used to reverse heparin), but this is unrelated to alteplase 1, 15.

• Bleeding risk: The primary concern when using alteplase is hemorrhage, not allergy 3. The FDA label for alteplase notes that concomitant heparin increases bleeding risk, but this is a pharmacodynamic interaction, not an allergic cross-reaction 3.

Bottom line: Heparin allergy does not predict or contraindicate alteplase use. These are separate drug entities with no immunologic cross-reactivity.